Inspire Medical Systems (INSP) Net Income towards Common Stockholders (2017 - 2026)
Inspire Medical Systems' Net Income towards Common Stockholders history spans 10 years, with the latest figure at -$11.3 million for Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 477.47% to -$11.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $131.1 million, a 97.25% increase, with the full-year FY2025 number at $145.4 million, up 171.77% from a year prior.
- Net Income towards Common Stockholders hit -$11.3 million in Q1 2026 for Inspire Medical Systems, down from $136.0 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for INSP hit a ceiling of $136.0 million in Q4 2025 and a floor of -$16.8 million in Q3 2022.
- Historically, Net Income towards Common Stockholders has averaged $7.2 million across 5 years, with a median of -$3.6 million in 2025.
- Biggest five-year swings in Net Income towards Common Stockholders: surged 368.67% in 2023 and later crashed 477.47% in 2026.
- Tracing INSP's Net Income towards Common Stockholders over 5 years: stood at $3.2 million in 2022, then surged by 368.67% to $14.8 million in 2023, then surged by 138.6% to $35.2 million in 2024, then skyrocketed by 286.23% to $136.0 million in 2025, then tumbled by 108.3% to -$11.3 million in 2026.
- Business Quant data shows Net Income towards Common Stockholders for INSP at -$11.3 million in Q1 2026, $136.0 million in Q4 2025, and $9.9 million in Q3 2025.